General Electric Extends Strategic Relationship With Australian-based Nanosonics to Expand Healthcare Innovation Globally
General Electric (NYSE: GE) announced Sunday a $7.5 million investment in Australian-based Nanosonics Limited - a leader in the development of innovative technology for infection control - to further develop and distribute Trophon EPR, an ultrasound transducer disinfecting system. The investment is being made through the GE healthymagination Fund, which makes investments in healthcare technology companies.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.